D07.39
Carcinoma in situ of other female genital organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the female genital organs refers to a group of early, non-invasive pre-cancerous conditions where abnormal cells are found within the tissues of the reproductive organs. Specifically, the ICD-10 code D07.39 pertains to carcinoma in situ affecting female genital organs other than the cervix, such as the vulva, vaginal walls, or other associated areas. Recognizing and understanding this condition is crucial, as it often signifies a precancerous stage that, if untreated, may develop into invasive cancer.
Causes & Symptoms
Clinical Causes: Persistent infection with high-risk human papillomavirus (HPV) types Genetic factors and family history of genital cancers Chronic irritation or inflammation of genital tissues Immunosuppression conditions, such as HIV/AIDS or immunosuppressive therapy Tobacco use and other lifestyle factors that impair immune response Previous history of genital neoplasia or precancerous conditions
Key Symptoms: Usually asymptomatic in early stages, leading to incidental findings during examinations Localized lesions that may appear as patches, plaques, or rough areas on genital skin or mucosa Possible itching, soreness, or burning sensation in affected areas Presence of abnormal lesions or pigmented areas on the vulva or vaginal walls Occasional bleeding or discomfort during sexual activity Changes in skin texture or color, such as white, red, or pigmented areas
Diagnostic & Treatment
Diagnosis Path: Detection of carcinoma in situ typically involves a combination of clinical examination and diagnostic procedures:
Treatment Protocols: Management of carcinoma in situ aims to remove abnormal cells and prevent progression to invasive cancer. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is D07.39 a billable ICD-10 code?
Yes, D07.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D07.39?
Clinical documentation must specify the nature of Carcinoma in situ of other female genital organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference